Further studies demonstrated that IL-23/IL-17 axis was involved in the pathogenesis of multiple rheumatoid diseases, including spondyloarthritis, psoriasis, rheumatoid arthritis, and inflammatory bowel diseases [12–14]. Here, IL17A is linked to rheumatoid arthritis.